Caplin Point Laboratories, 524742, CAPLIPOINT Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

14,328.58
27.81
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

13,795.00
0.27%
5.34

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
14.44
10.10

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
16.22
6.93

PAT CAGR (%)

10 Years
5 Years
3 Years

-
16.28
15.09

P:E (Median)

8 Years
5 Years
3 Years

19.89
19.69
21.09

P:BV (Average)

8 Years
5 Years
3 Years

6.32
4.31
4.46

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.30
14.24
15.47

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 60.19 69.97 76.42 93.02
P/E Ratio 34.6 29.76 27.25 22.39
Revenue 1694 1949 2220 2560
EBITDA 551 646 743 865
Net Income 457 514 580 706
ROA 18.7 22.1 20.8 21.1
P/B Ratio 7.06 5.75 4.69 4.11
ROE 22.59 20.1 18.6 18.7
FCFF 215.52 324.9 418.99 504.05
FCFF Yield 1.4 2.11 2.72 3.28

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 185.23 132.83 39.45% 207.93 179.22 16.02% 185.64 173.66 6.90% 139.38 144.67 -3.66%
Expenses 107.84 69.51 55.14% 109.77 89.77 22.28% 104.26 97.04 7.44% 81.70 79.80 2.38%
EBITDA 77.39 63.32 22.22% 98.16 89.45 9.74% 81.38 76.62 6.21% 57.68 64.87 -11.08%
EBIDTM 41.78% 47.67% 47.21% 49.91% 43.84% 44.12% 41.38% 44.84%
Other Income 28.83 17.90 61.06% 43.01 24.49 75.62% 21.50 27.27 -21.16% 36.18 12.22 196.07%
Interest 0.04 0.03 33.33% 0.02 0.02 0.00% 0.02 0.03 -33.33% 0.02 0.03 -33.33%
Depreciation 6.01 6.76 -11.09% 6.49 6.72 -3.42% 6.18 6.67 -7.35% 6.93 6.29 10.17%
PBT 100.17 74.43 34.58% 134.66 107.20 25.62% 96.68 97.19 -0.52% 86.91 70.77 22.81%
Tax 25.46 18.98 34.14% 28.92 25.10 15.22% 24.14 20.92 15.39% 17.03 16.44 3.59%
PAT 74.71 55.45 34.73% 105.74 82.10 28.79% 72.54 76.27 -4.89% 69.88 54.33 28.62%
PATM 40.33% 41.75% 50.85% 45.81% 39.08% 43.92% 50.14% 37.55%
EPS 9.83 7.30 34.66% 13.91 10.80 28.80% 9.54 10.04 -4.98% 9.19 7.15 28.53%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 492.96 435.50 13.19% 483.10 410.06 17.81% 458.96 395.32 16.10% 453.22 389.28 16.43%
Expenses 330.67 293.22 12.77% 318.34 272.66 16.75% 307.15 268.79 14.27% 307.99 265.35 16.07%
EBITDA 162.29 142.28 14.06% 164.76 137.40 19.91% 151.81 126.53 19.98% 145.23 123.93 17.19%
EBIDTM 32.92% 32.67% 34.10% 33.51% 33.08% 32.01% 32.04% 31.84%
Other Income 31.36 17.18 82.54% 20.77 20.43 1.66% 18.56 12.04 54.15% 17.29 11.40 51.67%
Interest 0.18 0.17 5.88% 0.21 0.18 16.67% 0.05 0.28 -82.14% 0.15 0.23 -34.78%
Depreciation 16.20 13.90 16.55% 16.76 11.76 42.52% 15.96 11.38 40.25% 16.40 11.13 47.35%
PBT 177.27 145.39 21.93% 168.56 145.89 15.54% 154.36 126.91 21.63% 145.97 123.97 17.75%
Tax 37.19 25.59 45.33% 37.65 29.86 26.09% 29.46 22.76 29.44% 24.80 22.81 8.72%
PAT 140.08 119.80 16.93% 130.91 116.03 12.82% 124.90 104.15 19.92% 121.17 101.16 19.78%
PATM 28.42% 27.51% 27.10% 28.30% 27.21% 26.35% 26.74% 25.99%
EPS 18.28 15.43 18.47% 17.21 15.12 13.82% 16.31 13.62 19.75% 16.01 13.45 19.03%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Net Sales 718.18 625.09 528.61 528.06 482.68 527.83 536.91 426.57 341.55 231.29 240.23 Net Sales Growth 13.93% 18.25% 0.10% 9.40% -8.55% -1.69% 25.87% 24.89% 47.67% -3.72% Cost Of Goods Sold 226.37 205.22 198.06 204.65 194.83 238.18 237.03 180.11 161.94 116.73 128.25 Gross Profit 491.81 419.87 330.55 323.41 287.85 289.65 299.87 246.46 179.61 114.56 111.98 GP Margin 68.48% 67.17% 62.53% 61.24% 59.64% 54.88% 55.85% 57.78% 52.59% 49.53% 46.61% Total Expenditure 403.57 338.01 309.23 308.58 273.14 320.83 348.31 284.33 247.72 168.78 183.03 Power & Fuel Cost - 15.43 9.89 9.54 6.36 7.19 12.29 10.96 9.85 7.55 8.39 % Of Sales - 2.47% 1.87% 1.81% 1.32% 1.36% 2.29% 2.57% 2.88% 3.26% 3.49% Employee Cost - 37.18 35.81 29.91 26.03 24.39 40.49 37.29 29.48 17.58 17.84 % Of Sales - 5.95% 6.77% 5.66% 5.39% 4.62% 7.54% 8.74% 8.63% 7.60% 7.43% Manufacturing Exp. - 54.17 42.18 34.68 27.15 33.34 38.72 37.02 28.34 13.84 15.59 % Of Sales - 8.67% 7.98% 6.57% 5.62% 6.32% 7.21% 8.68% 8.30% 5.98% 6.49% General & Admin Exp. - 18.24 13.52 12.55 6.50 8.55 14.96 12.18 12.63 7.60 7.43 % Of Sales - 2.92% 2.56% 2.38% 1.35% 1.62% 2.79% 2.86% 3.70% 3.29% 3.09% Selling & Distn. Exp. - 1.88 3.91 12.23 2.78 5.89 2.64 4.74 5.37 2.11 2.62 % Of Sales - 0.30% 0.74% 2.32% 0.58% 1.12% 0.49% 1.11% 1.57% 0.91% 1.09% Miscellaneous Exp. - 5.89 5.86 5.02 9.49 3.29 2.17 2.03 0.11 3.38 2.62 % Of Sales - 0.94% 1.11% 0.95% 1.97% 0.62% 0.40% 0.48% 0.03% 1.46% 1.21% EBITDA 314.61 287.08 219.38 219.48 209.54 207.00 188.60 142.24 93.83 62.51 57.20 EBITDA Margin 43.81% 45.93% 41.50% 41.56% 43.41% 39.22% 35.13% 33.35% 27.47% 27.03% 23.81% Other Income 129.52 105.84 99.54 56.69 23.01 65.97 35.40 23.31 12.51 3.47 2.74 Interest 0.10 0.10 0.12 0.09 0.17 0.19 0.50 0.52 0.50 0.31 0.87 Depreciation 25.61 27.08 25.65 25.77 22.44 19.65 20.84 18.99 13.26 7.30 8.28 PBT 418.42 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 50.80 Tax 95.55 82.03 58.89 62.44 53.71 55.49 54.49 43.74 22.26 13.05 9.86 Tax Rate 22.84% 22.43% 20.09% 24.95% 25.58% 21.92% 26.89% 29.95% 24.04% 22.35% 19.41% PAT 322.87 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 40.94 PAT before Minority Interest 322.87 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 40.94 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 44.96% 45.39% 44.32% 35.58% 32.37% 37.44% 27.60% 23.98% 20.59% 19.60% 17.04% PAT Growth 20.41% 21.11% 24.69% 20.25% -20.95% 33.39% 44.82% 45.49% 55.13% 10.72% EPS 42.48 37.33 30.82 24.72 20.56 26.01 19.50 13.46 9.25 5.96 5.39

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Net Sales 1,888.24 1,694.10 1,466.73 1,269.41 1,061.29 863.20 648.69 539.84 401.65 238.72 251.77 Net Sales Growth 15.83% 15.50% 15.54% 19.61% 22.95% 33.07% 20.16% 34.41% 68.25% -5.18% Cost Of Goods Sold 761.02 724.18 663.21 557.51 471.74 413.16 288.78 238.18 184.93 121.16 135.62 Gross Profit 1,127.22 969.92 803.52 711.90 589.55 450.04 359.91 301.66 216.72 117.56 116.15 GP Margin 59.70% 57.25% 54.78% 56.08% 55.55% 52.14% 55.48% 55.88% 53.96% 49.25% 46.13% Total Expenditure 1,264.15 1,142.65 1,026.21 874.88 737.04 603.13 416.84 344.52 276.84 174.51 192.06 Power & Fuel Cost - 33.57 25.53 21.40 16.36 14.81 13.76 10.98 9.91 7.56 8.61 % Of Sales - 1.98% 1.74% 1.69% 1.54% 1.72% 2.12% 2.03% 2.47% 3.17% 3.42% Employee Cost - 142.66 136.12 114.74 101.97 67.15 45.58 37.61 29.71 17.92 18.24 % Of Sales - 8.42% 9.28% 9.04% 9.61% 7.78% 7.03% 6.97% 7.40% 7.51% 7.24% Manufacturing Exp. - 117.73 90.99 82.01 69.85 68.23 43.49 37.11 28.56 14.33 16.04 % Of Sales - 6.95% 6.20% 6.46% 6.58% 7.90% 6.70% 6.87% 7.11% 6.00% 6.37% General & Admin Exp. - 89.41 85.38 66.68 38.53 25.50 20.82 12.27 13.78 8.15 7.97 % Of Sales - 5.28% 5.82% 5.25% 3.63% 2.95% 3.21% 2.27% 3.43% 3.41% 3.17% Selling & Distn. Exp. - 28.44 18.78 27.52 18.03 9.95 2.08 5.92 9.41 2.29 2.85 % Of Sales - 1.68% 1.28% 2.17% 1.70% 1.15% 0.32% 1.10% 2.34% 0.96% 1.13% Miscellaneous Exp. - 6.66 6.20 5.02 20.56 4.33 2.33 2.45 0.55 3.10 2.85 % Of Sales - 0.39% 0.42% 0.40% 1.94% 0.50% 0.36% 0.45% 0.14% 1.30% 1.08% EBITDA 624.09 551.45 440.52 394.53 324.25 260.07 231.85 195.32 124.81 64.21 59.71 EBITDA Margin 33.05% 32.55% 30.03% 31.08% 30.55% 30.13% 35.74% 36.18% 31.07% 26.90% 23.72% Other Income 87.98 66.94 56.52 38.89 27.93 41.33 19.03 12.67 9.96 3.66 3.03 Interest 0.59 0.78 0.78 0.70 1.59 0.32 0.58 0.61 0.52 0.34 0.97 Depreciation 65.32 53.44 44.99 46.90 36.97 31.62 23.43 19.00 13.30 7.48 8.38 PBT 646.16 564.17 451.27 385.82 313.62 269.46 226.88 188.38 120.95 60.05 53.39 Tax 129.10 103.01 74.36 77.37 62.19 54.38 50.32 43.74 25.44 14.28 12.26 Tax Rate 19.98% 18.26% 16.48% 20.05% 19.83% 20.18% 22.18% 23.22% 21.03% 23.78% 22.96% PAT 517.06 457.09 376.26 299.84 242.27 215.00 176.56 144.78 95.61 45.77 41.04 PAT before Minority Interest 515.35 461.42 376.99 308.45 251.43 215.08 176.56 144.63 95.50 45.77 41.13 Minority Interest -1.71 -4.33 -0.73 -8.61 -9.16 -0.08 0.00 0.15 0.11 0.00 -0.09 PAT Margin 27.38% 26.98% 25.65% 23.62% 22.83% 24.91% 27.22% 26.82% 23.80% 19.17% 16.30% PAT Growth 17.21% 21.48% 25.49% 23.76% 12.68% 21.77% 21.95% 51.43% 108.89% 11.53% EPS 68.03 60.14 49.51 39.45 31.88 28.29 23.23 19.05 12.58 6.02 5.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Shareholder's Funds 1,390.15 1,139.91 930.65 758.67 599.91 432.04 295.60 200.12 128.14 93.63 Share Capital 15.19 15.18 15.16 15.13 15.13 15.13 15.12 15.12 15.11 15.11 Total Reserves 1,360.74 1,109.36 900.04 728.75 575.34 410.06 277.19 184.91 111.40 78.52 Non-Current Liabilities 12.86 16.42 24.63 24.99 27.16 24.77 27.86 19.90 13.69 10.39 Secured Loans 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 0.88 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 1.63 0.82 Current Liabilities 119.30 146.85 98.88 77.33 64.26 82.51 87.34 97.05 120.77 119.18 Trade Payables 78.62 70.63 65.02 70.11 51.41 59.50 72.89 66.01 51.47 38.04 Other Current Liabilities 36.26 65.26 32.66 6.06 11.97 21.76 13.86 29.37 60.37 71.36 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Short Term Provisions 4.42 10.96 1.20 1.16 0.87 1.25 0.58 1.67 8.92 9.73 Total Liabilities 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 223.20 Net Block 165.79 156.85 162.46 182.68 166.93 137.77 169.32 151.75 142.75 111.47 Gross Block 318.45 285.13 268.64 266.22 228.35 179.85 231.63 195.07 178.70 140.64 Accumulated Depreciation 152.66 128.28 106.18 83.54 61.43 42.08 62.31 43.32 35.94 29.17 Non Current Assets 819.21 641.48 448.49 348.35 310.59 251.37 197.59 180.34 147.78 146.11 Capital Work in Progress 27.75 42.68 2.60 1.36 3.77 8.62 15.29 3.42 0.23 30.63 Non Current Investment 346.17 274.97 212.73 138.64 135.54 98.62 1.87 14.58 1.43 1.44 Long Term Loans & Adv. 272.07 164.70 70.70 5.67 4.36 6.36 11.11 10.59 3.37 2.57 Other Non Current Assets 7.43 2.28 0.00 20.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 703.10 661.70 605.67 512.64 380.74 287.95 213.21 136.73 114.82 77.10 Current Investments 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 0.00 0.00 Inventories 86.25 51.53 42.81 24.87 22.37 23.52 28.46 22.29 17.90 12.66 Sundry Debtors 128.67 88.24 53.73 98.46 218.98 125.39 86.35 3.21 6.80 0.02 Cash & Bank 215.78 271.38 316.08 345.49 58.27 44.85 28.28 76.66 64.77 40.32 Other Current Assets 34.42 2.17 11.97 18.31 20.89 24.56 23.78 30.37 25.35 24.10 Short Term Loans & Adv. 32.15 38.20 129.11 14.97 10.57 15.95 17.00 23.05 14.93 18.59 Net Current Assets 583.80 514.85 506.79 435.31 316.48 205.44 125.87 39.67 -5.95 -42.08 Total Assets 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 223.21

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Shareholder's Funds 2,315.71 1,880.48 1,483.93 1,185.83 947.91 632.91 363.83 224.76 128.14 93.19 Share Capital 89.77 89.76 89.74 89.71 89.71 51.05 15.12 15.12 15.11 15.11 Total Reserves 2,211.72 1,775.35 1,378.74 1,081.33 848.76 575.01 345.42 209.56 111.40 78.08 Non-Current Liabilities 7.46 2.13 12.55 17.39 24.86 23.42 27.86 19.90 13.69 10.39 Secured Loans 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 0.88 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 8.61 7.78 8.48 5.69 5.23 0.13 0.00 0.40 1.63 0.82 Current Liabilities 331.28 268.00 207.68 142.85 144.32 86.11 108.67 113.36 125.04 124.97 Trade Payables 209.41 152.56 155.94 88.50 64.14 60.47 94.23 78.60 55.71 41.56 Other Current Liabilities 110.50 99.94 48.68 51.87 79.28 24.20 13.86 33.09 60.39 72.11 Short Term Borrowings 0.28 3.41 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Short Term Provisions 11.09 12.09 2.56 2.48 0.91 1.44 0.58 1.67 8.94 11.25 Total Liabilities 2,685.57 2,177.40 1,730.11 1,363.61 1,125.75 742.52 500.45 358.38 267.14 228.82 Net Block 452.66 279.81 286.57 305.34 272.50 226.84 169.48 151.83 144.23 113.13 Gross Block 702.31 480.32 445.74 422.58 354.79 271.51 231.79 195.15 180.76 142.71 Accumulated Depreciation 249.65 200.51 159.17 117.24 82.29 44.67 62.31 43.31 36.53 29.58 Non Current Assets 792.65 625.21 432.29 349.04 303.23 248.83 196.34 179.16 148.61 146.95 Capital Work in Progress 116.62 220.71 17.73 13.88 20.12 9.70 15.29 3.42 0.23 30.63 Non Current Investment 137.63 70.52 37.01 0.66 0.56 0.33 0.33 13.24 0.44 0.45 Long Term Loans & Adv. 78.31 51.51 89.90 7.92 10.05 11.95 11.23 10.67 3.71 2.75 Other Non Current Assets 7.43 2.66 1.08 21.24 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,892.92 1,552.19 1,297.82 1,014.57 822.53 493.69 304.11 179.22 118.53 81.87 Current Investments 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 0.00 0.00 Inventories 363.04 288.22 227.31 179.01 238.23 37.45 28.46 22.29 18.81 13.66 Sundry Debtors 542.72 394.06 317.05 279.36 228.96 159.81 125.88 33.02 7.95 5.66 Cash & Bank 552.74 493.48 462.99 438.33 223.43 152.99 79.28 93.07 68.10 45.37 Other Current Assets 196.44 22.82 13.61 20.25 71.68 73.83 24.16 26.63 23.67 17.18 Short Term Loans & Adv. 146.01 143.43 224.89 87.08 56.81 64.61 17.28 19.31 12.58 11.08 Net Current Assets 1,561.64 1,284.19 1,090.14 871.72 678.21 407.58 195.44 65.86 -6.51 -43.10 Total Assets 2,685.57 2,177.40 1,730.11 1,363.61 1,125.76 742.52 500.45 358.38 267.14 228.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Cash From Operating Activity 111.01 157.10 230.97 294.64 87.01 107.34 22.61 55.49 44.37 49.53 PBT 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 50.80 Adjustment -68.57 -59.57 -19.43 7.75 -32.58 -0.29 3.44 8.06 3.89 6.32 Changes in Working Capital -99.07 -11.45 62.07 131.85 -83.19 -54.17 -92.59 -24.76 -7.20 1.91 Cash after chg. in Working capital 198.10 222.13 292.95 349.54 137.36 148.19 56.90 75.88 55.07 59.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -87.09 -65.03 -61.98 -54.90 -50.35 -40.84 -34.29 -20.39 -10.69 -9.50 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -118.94 -86.67 -275.93 -3.71 -41.06 -76.51 -59.71 -37.07 -5.98 -23.76 Net Fixed Assets -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 -25.72 Net Investments -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 -0.90 Others -1.55 190.35 -156.75 -14.84 30.12 -14.93 18.15 -0.16 1.67 2.86 Cash from Financing Activity -34.26 -30.42 -22.76 -3.47 -32.92 -15.21 -11.60 -6.74 -13.95 -8.62 Net Cash Inflow / Outflow -42.19 40.01 -67.72 287.46 13.03 15.62 -48.70 11.67 24.45 17.15 Opening Cash & Equivalents 122.02 81.01 148.82 55.61 42.52 26.18 74.89 63.22 40.32 23.17 Closing Cash & Equivalent 80.64 122.02 81.01 342.88 55.61 42.52 26.18 74.89 64.77 40.32

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Cash From Operating Activity 318.39 271.37 336.73 268.61 44.68 83.42 66.49 67.61 42.40 49.88 PBT 564.43 451.35 385.82 313.62 269.46 226.88 188.38 120.95 60.05 53.39 Adjustment 2.40 11.77 30.44 23.09 7.09 19.12 14.84 8.61 3.87 6.21 Changes in Working Capital -139.44 -103.75 1.96 -1.96 -177.11 -120.06 -100.38 -38.39 -5.13 1.96 Cash after chg. in Working capital 427.39 359.37 418.22 334.75 99.44 125.94 102.84 91.16 58.78 61.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -109.00 -88.00 -81.49 -66.14 -54.76 -42.51 -36.35 -23.55 -16.38 -11.67 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -320.04 -217.58 -376.77 -29.44 -54.50 -100.46 -69.02 -36.11 -5.72 -22.66 Net Fixed Assets -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 -25.72 Net Investments -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 -0.90 Others -202.65 59.44 -257.59 -40.57 16.68 -38.88 8.84 0.80 1.93 3.96 Cash from Financing Activity -38.07 -28.17 -40.68 -23.98 79.77 89.79 -11.60 -6.74 -13.95 -8.67 Net Cash Inflow / Outflow -39.72 25.62 -80.72 215.19 69.94 72.76 -14.13 24.76 22.73 18.55 Opening Cash & Equivalents 177.56 150.76 231.57 220.77 150.65 77.17 91.31 66.55 45.37 26.82 Closing Cash & Equivalent 138.55 170.92 150.76 435.72 220.77 150.65 77.17 91.31 68.10 45.37

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Book Value (Rs.) 181.16 148.16 120.74 98.33 78.06 56.22 38.66 26.47 16.25 11.90 ROA 20.08% 19.87% 19.62% 20.13% 32.12% 31.19% 28.11% 24.26% 18.66% 20.60% ROE 22.69% 22.97% 22.65% 23.42% 38.92% 41.30% 41.56% 43.57% 42.62% 55.15% ROCE 28.92% 28.33% 29.64% 30.92% 49.05% 55.76% 58.99% 56.89% 53.75% 67.20% Fixed Asset Turnover 2.07 1.91 1.97 1.95 2.59 2.61 2.00 1.83 1.45 1.84 Receivable days 63.33 49.01 52.60 120.02 119.07 71.97 38.32 5.35 5.38 0.02 Inventory Days 40.23 32.57 23.39 17.86 15.87 17.67 21.71 21.48 24.11 15.55 Payable days 132.73 124.99 120.50 113.83 61.02 67.67 86.81 85.61 98.57 65.47 Cash Conversion Cycle -29.17 -43.41 -44.52 24.05 73.91 21.97 -26.78 -58.79 -69.08 -49.90 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 Interest Cover 3658.40 2443.92 2782.22 1235.94 1369.24 404.61 281.22 185.02 190.79 59.55

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15
Book Value (Rs.) 293.21 235.91 183.89 144.94 114.21 78.03 47.69 29.73 16.25 11.84 ROA 18.98% 19.30% 19.94% 20.20% 23.02% 28.41% 33.68% 30.54% 18.46% 20.12% ROE 22.97% 23.68% 24.77% 25.65% 29.58% 37.14% 49.43% 54.97% 43.13% 55.78% ROCE 26.92% 26.85% 28.77% 28.82% 33.35% 45.59% 64.08% 69.03% 55.41% 71.11% Fixed Asset Turnover 2.87 3.17 2.92 2.73 2.76 2.58 2.53 2.14 1.48 1.89 Receivable days 100.92 88.48 85.74 87.41 82.19 80.37 53.72 18.62 10.40 4.17 Inventory Days 70.16 64.15 58.42 71.75 58.28 18.54 17.16 18.68 24.83 17.00 Payable days 91.22 84.89 80.02 59.05 28.33 65.76 89.68 88.17 103.48 69.75 Cash Conversion Cycle 79.85 67.73 64.14 100.11 112.15 33.15 -18.80 -50.88 -68.24 -48.58 Total Debt/Equity 0.00 0.00 0.00 0.01 0.04 0.00 0.00 0.00 0.02 0.02 Interest Cover 724.63 579.65 552.17 198.25 843.86 391.22 309.72 235.08 179.35 56.11

Top Investors:

investor education and protection fund authority ministry of corporate affairs

uti small cap fund

llp

Annual Reports:

News Update:

Caplin Point Laboratories’ arm gets USFDA’s approval for Phytonadione Injectable Emulsion
23rd Apr 2025, 15:18 PM

Phytonadione Injectable Emulsion had US sales of around $18.5 million for the 12-month period ending February 2025
Read More
Caplin Point Laboratories’ arm acquires Neoethicals Chile SpA
2nd Apr 2025, 17:05 PM

The Caplin Point Far East’s board had approved the investment in Neoethicals Chile SpA through the purchase of all its shares
Read More
Caplin Point’s arm gets USFDA’s final nod for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
27th Feb 2025, 09:37 AM

Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution had US sales of around $242 million for the 12-month period ending December 2024
Read More
Caplin Point Lab - Quarterly Results
7th Feb 2025, 13:15 PM

Read More
Caplin Point’s arm gets USFDA’s approval for Procainamide Hydrochloride Injection
5th Feb 2025, 12:20 PM

It restores normal heart rhythm by blocking abnormal electrical signals in the heart
Read More

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524742 | NSE: CAPLIPOINT

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524742 | NSE: CAPLIPOINT

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: